About this episode
Sanfilippo syndrome is a rare and degenerative disease that can be fatal by the time someone reaches their teens. So the O’Neill family knew they didn’t have much time after learning their 4-year old daughter, Eliza, had it. At the time no treatment existed, and the world of drug development had its eyes on more common illnesses. So the family took an all hands on deck, unusual approach to directly raise money and boost medical research. NPR pharmaceutical correspondent Sydney Lupkin shares what happened next, and what she learned from the O’Neills story about the promises and challenges of drug development. Interested in more medical science? Email us your question at shortwave@npr.org . Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy
Comments
Rate this episode
Episode Details
- Show Type
- full
- Audio Format
- audio/mpeg
